Number of patients receiving any implantable cardioverter defibrillator who received a model that accrued sufficient utilization 2 years post‐first implantation to detect safety differences for adverse event and complication rates of 3.9, 6.1, and 12.6 events per 100 person‐years and rate ratios of 1.05, 1.15, 1.25, 1.50, and 2.00 at significance level α=0.05